Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Sponsor: Cedars-Sinai Medical Center
This NA trial investigates Ampullary Cancer and Anal Cancer and is currently actively recruiting participants. Cedars-Sinai Medical Center leads this study, which shows 12 recorded versions since 2021 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
12 versions recorded-
Feb 2026 — Present [monthly]
Recruiting NA
-
Nov 2025 — Feb 2026 [monthly]
Recruiting NA
-
Nov 2024 — Nov 2025 [monthly]
Recruiting NA
-
Sep 2024 — Nov 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
▶ Show 7 earlier versions
-
Jul 2023 — Jul 2024 [monthly]
Recruiting NA
Phase: PHASE2 → NA
-
Jun 2023 — Jul 2023 [monthly]
Recruiting PHASE2
-
Feb 2023 — Jun 2023 [monthly]
Recruiting PHASE2
-
Sep 2022 — Feb 2023 [monthly]
Recruiting PHASE2
-
Mar 2022 — Sep 2022 [monthly]
Recruiting PHASE2
-
Feb 2022 — Mar 2022 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting · Phase: NA → PHASE2
-
Sep 2021 — Feb 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cedars-Sinai Medical Center
- National Cancer Institute (NCI)
- University of California, Los Angeles
For direct contact, visit the study record on ClinicalTrials.gov .